Cargando…

Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms

Antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in serum and cerebrospinal fluid (CSF) samples from 16 patients with coronavirus disease 2019 and neurological symptoms were assessed using 2 independent methods. Immunoglobulin G (IgG) specific for the virus spike pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunningham, Janet L, Virhammar, Johan, Rönnberg, Bengt, Dopico, Xaquin Castro, Kolstad, Linda, Albinsson, Bo, Kumlien, Eva, Nääs, Anja, Klang, Andrea, Westman, Gabriel, Zetterberg, Henrik, Frithiof, Robert, Lundkvist, Åke, Karlsson Hedestam, Gunilla B, Rostami, Elham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083780/ https://www.ncbi.nlm.nih.gov/pubmed/33744954 http://dx.doi.org/10.1093/infdis/jiab153

Ejemplares similares

Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID‐19 and associated with neurological symptoms and disease severity
por: Virhammar, Johan, et al.
Publicado: (2021)

Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2
por: Hoffman, Tove, et al.
Publicado: (2021)

Immunity to SARS‐CoV‐2 induced by infection or vaccination
por: Castro Dopico, Xaquin, et al.
Publicado: (2021)

Antibody responses to tick-borne encephalitis virus non-structural protein 1 and whole virus antigen–a new tool in the assessment of suspected vaccine failure patients
por: Albinsson, Bo, et al.
Publicado: (2019)

Enhanced B Cell Receptor Signaling Partially Compensates for Impaired Toll-like Receptor 4 Responses in LPS-Stimulated IκBNS-Deficient B Cells
por: Adori, Monika, et al.
Publicado: (2023)

Evaluation of Production Lots of a Rapid Point-of-Care Lateral Flow Serological Test Intended for Identification of IgM and IgG against the N-Terminal Part of the Spike Protein (S1) of SARS-CoV-2
por: Hoffman, Tove, et al.
Publicado: (2021)

Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017
por: Albinsson, Bo, et al.
Publicado: (2018)

Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid
por: Virhammar, Johan, et al.
Publicado: (2020)

The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive care
por: Fällmar, David, et al.
Publicado: (2022)

Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2
por: Hoffman, Tove, et al.
Publicado: (2023)

Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study
por: Frithiof, Robert, et al.
Publicado: (2021)

Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses
por: Pushparaj, Pradeepa, et al.
Publicado: (2023)

COVID‐19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients
por: Sundberg, Emil, et al.
Publicado: (2022)

Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019( )
por: Castanha, Priscila M S, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses
por: Lawrenz, Jan, et al.
Publicado: (2022)

Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Magnus, Maria C, et al.
Publicado: (2022)

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study
por: Sheward, Daniel J, et al.
Publicado: (2022)

Dying at Home Due to Coronavirus Disease 2019
por: Edwards, Jessie K, et al.
Publicado: (2022)

Racial, Ethnic, and Geographic Disparities in Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Test Positivity in North Carolina
por: Turner, Nicholas A, et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

Serogrouping and seroepidemiology of North European hantaviruses using a novel broadly targeted synthetic nucleoprotein antigen array
por: Rönnberg, Bengt, et al.
Publicado: (2017)

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021
por: Couture, Alexia, et al.
Publicado: (2022)

Serology in the Digital Age: Using Long Synthetic Peptides Created from Nucleic Acid Sequences as Antigens in Microarrays
por: Rizwan, Muhammad, et al.
Publicado: (2016)

Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies
por: Khatri, Akshay, et al.
Publicado: (2021)

Inactivation of surrogate coronaviruses on hard surfaces by health care germicides
por: Hulkower, Rachel L., et al.
Publicado: (2011)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
por: Clancy, Cornelius J, et al.
Publicado: (2022)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
por: Wiemken, Timothy L, et al.
Publicado: (2022)

Incidence and Prevalence of Coronavirus Disease 2019 Within a Healthcare Worker Cohort During the First Year of the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic( )
por: Doernberg, Sarah B, et al.
Publicado: (2022)

Low Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission by Fomites: A Clinical Observational Study in Highly Infectious Coronavirus Disease 2019 Patients( )
por: Meister, Toni Luise, et al.
Publicado: (2022)

Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections
por: Rönnberg, Bengt, et al.
Publicado: (2017)

Indirect immunofluorescence for detecting anti-neuronal autoimmunity in CSF after COVID-19 – Possibilities and pitfalls
por: Mulder, Jan, et al.
Publicado: (2021)

Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2022)

Human Coronavirus-HKU1 Infection Among Adults in Cleveland, Ohio
por: Kanwar, Anubhav, et al.
Publicado: (2017)

The role of facial contact in infection control: Renewed import in the age of coronavirus
por: Christensen, Paul A., et al.
Publicado: (2021)

Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China
por: Cheng, Biheng, et al.
Publicado: (2020)

Spread of Coronavirus 2019 From Wuhan to Rural Villages in the Hubei Province
por: You, Maolin, et al.
Publicado: (2020)

Aspirin with or without statin in the treatment of endotheliitis, thrombosis, and ischemia in coronavirus disease
por: Florêncio, Francisco Kleyton Zacarias, et al.
Publicado: (2020)

Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_km1m84jrmvmmr16tfc6lpjjuqr